Delta-Fly Pharma, Inc. (4598.T)
JPY 496.0
(1.85%)
JPY 496.0
(1.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.4 Billion JPY | -6.66% |
| 2022 | -1.31 Billion JPY | -36.86% |
| 2021 | -961.46 Million JPY | -12.82% |
| 2020 | -852.23 Million JPY | 44.84% |
| 2019 | -1.54 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -497 Thousand JPY | 4.79% |
| 2023 FY | -1.4 Billion JPY | -6.66% |
| 2023 Q1 | -275.57 Million JPY | 4.79% |
| 2023 Q4 | -454.07 Million JPY | -27.57% |
| 2023 Q3 | -355.94 Million JPY | -11.98% |
| 2023 Q2 | -317.87 Million JPY | -15.35% |
| 2022 Q3 | -415 Million JPY | -35.02% |
| 2022 Q4 | -289.44 Million JPY | 30.26% |
| 2022 FY | -1.31 Billion JPY | -36.86% |
| 2022 Q2 | -307.36 Million JPY | 0.0% |
| 2021 FY | -961.46 Million JPY | -12.82% |
| 2020 FY | -852.23 Million JPY | 44.84% |
| 2019 FY | -1.54 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 335.078% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -182.369% |
| GNI Group Ltd. | 13.1 Billion JPY | 110.703% |
| Linical Co., Ltd. | 725.72 Million JPY | 293.324% |
| Trans Genic Inc. | 89.43 Million JPY | 1668.72% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 1.61% |
| Soiken Holdings Inc. | -610 Million JPY | -129.997% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -81.561% |
| AnGes, Inc. | -11.96 Billion JPY | 88.277% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -25.179% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 85.272% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1445.171% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -62.306% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -25.607% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -11.173% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -75.692% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -315.87% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -16.415% |
| Kidswell Bio Corporation | -1.33 Billion JPY | -5.047% |
| PeptiDream Inc. | 6.77 Billion JPY | 120.714% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 27.305% |
| Ribomic Inc. | -1.11 Billion JPY | -25.695% |
| SanBio Company Limited | -4.53 Billion JPY | 69.09% |
| Healios K.K. | -3.37 Billion JPY | 58.479% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -21.464% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | -0.681% |
| StemRIM | -2.07 Billion JPY | 32.418% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 214.859% |
| FunPep Company Limited | -994 Million JPY | -41.147% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -57.86% |
| Stella Pharma Corporation | -760.3 Million JPY | -84.532% |
| TMS Co., Ltd. | -943.25 Million JPY | -48.741% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -80.941% |
| Cuorips Inc. | -588.48 Million JPY | -138.408% |
| K Pharma,Inc. | 366.05 Million JPY | 483.274% |
| Takara Bio Inc. | 3 Billion JPY | 146.72% |
| ReproCELL Incorporated | -409.29 Million JPY | -242.786% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 12781.913% |
| StemCell Institute Inc. | 413.75 Million JPY | 439.086% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 1070.887% |
| CellSeed Inc. | -697.77 Million JPY | -101.067% |